Welcome to Campus Sanofi UAE
Access all the content and events you need to continue growing as a health professional.
Latest trends
Explore the most popular scientific articles and videos among Campus Sanofi users
Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease
EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP
An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.
VESTIGE Trial Results: Dupilumab in Type 2 Asthma
This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.
New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention
Considerations for bullous pemphigoid management
The management of bullous pemphigoid is challenging and new treatment approaches are needed. Read this article to find out more.
Treatments and challenges for bullous pemphigoid
Systemic corticosteroids and other immunosuppressants are the current mainstay of therapy but carry risks for patients with bullous pemphigoid. Read this article to find out more
Pathophysiology of Bullous Pemphigoid
In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more
Events
Stay up to date and register for the latest events and view webinar recordings
Support for your patients
Discover the selection of support materials for patients from different therapeutic areas
.jpg/jcr:content/thumb%20(8).jpg)
Why Praluent is the Optimal Choice for Post-ACS Patients?
Explore the compelling reasons why Praluent should be your first choice for patients with recent acute coronary syndrome who need to achieve their LDL-C goals. This informative video provides in-depth clinical insights and evidence, detailing how Praluent’s unique mechanism of action and proven efficacy can significantly improve patient outcomes. The video also covers tips on the 3 main factors: efficacy, safety, and administration to help you to integrate Praluent into your treatment plans. Enhance patient outcomes and elevate your practice with Praluent.
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
Ministry of Health organizes "KiDS" program at Expo 2020 Dubai to promote diabetes awareness at schools
